ARCHIVES

FDA Approves Generic Capecitabine

This article is from The Cancer Letter archive.

Vol. 39 No. 35 | September 20, 2013

Download PDF Visit The Full Archive

Related Articles

SPORE Eligibility, Cost Issues Clarified In Addendum To RFA

October 25, 1991

Satraplatin With Prednisone Reduces Risk Of Disease Progression By 33% In Study

March 30, 2007

Community-Based Program Final Planning Review In August, October

August 6, 1976

Six Panels To Help NCI Identify Progress; NCINews Roundup

January 8, 1993

Program Announcements Non-Invasive Detection Of Lung Cancer

April 15, 1983

Cancer Center Planning Grants Recompetition Approved By Advisors

June 10, 1994